| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.37B | 20.97B | 20.59B | 18.98B | 12.75B | 16.05B |
| Gross Profit | 20.22B | 20.97B | 20.02B | 18.19B | 12.21B | 15.62B |
| EBITDA | 2.54B | 4.16B | 5.06B | 4.65B | -1.41B | 5.24B |
| Net Income | 2.48B | 2.75B | 3.17B | 2.98B | -2.38B | 2.90B |
Balance Sheet | ||||||
| Total Assets | 116.78B | 124.32B | 109.53B | 124.12B | 98.83B | 104.72B |
| Cash, Cash Equivalents and Short-Term Investments | 21.05B | 24.24B | 25.98B | 35.51B | 24.87B | 28.09B |
| Total Debt | 25.30B | 24.91B | 19.99B | 18.90B | 12.76B | 7.95B |
| Total Liabilities | 70.90B | 67.17B | 61.93B | 65.46B | 44.81B | 46.70B |
| Stockholders Equity | 42.99B | 50.49B | 44.56B | 55.65B | 51.00B | 55.71B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 0.00 | -9.43B | 8.22B | -9.73B | -4.27B |
| Operating Cash Flow | 0.00 | 0.00 | -8.95B | 8.45B | -9.49B | -3.93B |
| Investing Cash Flow | 0.00 | 0.00 | 1.18B | 1.48B | 474.00M | 4.75B |
| Financing Cash Flow | 0.00 | 0.00 | -4.89B | -1.52B | 3.82B | 959.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥84.68B | 6.96 | ― | 5.75% | 30.59% | 55.29% | |
75 Outperform | ¥68.71B | 12.02 | 9.22% | 6.15% | 13.26% | 31.92% | |
70 Outperform | ¥203.32B | 4.29 | ― | 4.01% | 21.03% | 85.36% | |
68 Neutral | ¥45.42B | 16.68 | ― | 4.36% | 3.23% | -11.76% | |
68 Neutral | ¥37.90B | 18.08 | 7.66% | 5.47% | 12.83% | 32.86% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
57 Neutral | ¥43.72B | 11.76 | ― | 4.86% | 10.70% | 63.03% |